Morgan Stanley Maintains Doximity(DOCS.US) With Sell Rating, Maintains Target Price $25

Morgan Stanley analyst Craig Hettenbach maintains $Doximity(DOCS.US)$ with a sell rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 60.3% and

moomoo NewsJun 17 05:32 ET · Ratings

Should You Think About Buying Doximity, Inc. (NYSE:DOCS) Now?

Yahoo FinanceJun 16 08:12 ET

Doximity(DOCS.US) Director Sells US$300K in Common Stock

$Doximity(DOCS.US)$ Director Cabral Timothy S sold 10,000 shares of common stock on Jun 12, 2024 at an average price of $30 for a total value of $300K.Source: Announcement What is statement of changes

moomoo NewsJun 14 16:43 ET

Doximity(DOCS.US) Officer Sells US$900.01K in Common Stock

$Doximity(DOCS.US)$ Officer Bryson Anna sold 30,000 shares of common stock on Jun 12, 2024 at an average price of $30.0002 for a total value of $900.01K.Source: Announcement What is statement of chang

moomoo NewsJun 14 16:43 ET

Doximity Insider Sold Shares Worth $300,000, According to a Recent SEC Filing

Timothy S Cabral, Director, on June 12, 2024, sold 10,000 shares in Doximity (DOCS) for $300,000. Following the Form 4 filing with the SEC, Cabral has control over a total of 10,258 shares of the comp

MT NewswiresJun 14 16:05 ET

Is It Time To Consider Buying Doximity, Inc. (NYSE:DOCS)?

Doximity, Inc. (NYSE:DOCS), might not be a large cap stock, but it led the NYSE gainers with a relatively large price hike in the past couple of weeks. While good news for shareholders, the comp

Simply Wall StJun 13 08:21 ET